Last updated: Oct 23, 2026, 12:00 AM

Kymera Therapeutics Inc Exchange (NASDAQ, USD)

KYMR

-
+5.39 (+4.99%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
89.64%
3 year return (CAGR)
107.99%
5 year return (CAGR)
16.47%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
9.33B
Price/Sales
88.89
Ent value
9.35B
Price/Book
6.20
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
7.02%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Ready to capitalize on Kymera Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today